AZN: AstraZeneca, A Diversifying Covid Play

Several companies are competing to find a vaccine to combat the SARS-CoV-2 virus. We have talked about a few of the candidates, but not our 2nd favorite play. AstraZeneca.

This article is for paid members - please login or subscribe for access.

Share: